Novel Approaches to Improve Myeloma Cell Killing by Monoclonal Antibodies

The monoclonal antibodies (mAbs) have significantly changed the treatment of multiple myeloma (MM) patients. However, despite their introduction, MM remains an incurable disease. The mAbs currently used for MM treatment were developed with different mechanisms of action able to target antigens, such...

Descripción completa

Detalles Bibliográficos
Autores principales: Storti, Paola, Costa, Federica, Marchica, Valentina, Burroughs-Garcia, Jessica, dalla Palma, Benedetta, Toscani, Denise, Eufemiese, Rosa Alba, Giuliani, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564331/
https://www.ncbi.nlm.nih.gov/pubmed/32899714
http://dx.doi.org/10.3390/jcm9092864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564331/
https://www.ncbi.nlm.nih.gov/pubmed/32899714
http://dx.doi.org/10.3390/jcm9092864

Ejemplares similares